Cefuroxime axetil is a second-generation oral cephalosporin antibiotic used to treat various bacterial infections, including those affecting the respiratory tract, skin, and urinary tract. By inhibiting… Read more

![Chemical structure of (R)-1-Acetoxyethyl (6R,7R)-3-((carbamoyloxy)methyl)-7-((E)-2-(furan-2-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F127181-39-9-R-1-Acetoxyethyl-6R7R-3-carbamoyloxymethyl-7-E-2-furan-2-yl-2-methoxyiminoacetamido-8-oxo-5-thia-1-azabicyclo4.2.0oct-2-ene-2-carboxylate.png&w=3840&q=75)
![Chemical structure of (S)-1-Acetoxyethyl (6R,7R)-3-((carbamoyloxy)methyl)-7-((E)-2-(furan-2-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F127181-37-7-S-1-Acetoxyethyl-6R7R-3-carbamoyloxymethyl-7-E-2-furan-2-yl-2-methoxyiminoacetamido-8-oxo-5-thia-1-azabicyclo4.2.0oct-2-ene-2-carboxylate.png&w=3840&q=75)







Cefuroxime axetil is a second-generation oral cephalosporin antibiotic used to treat various bacterial infections, including those affecting the respiratory tract, skin, and urinary tract. By inhibiting bacterial cell wall synthesis through the binding of penicillin-binding proteins, this agent serves as a critical therapeutic option. To ensure the reliability of pharmaceutical research and manufacturing, laboratories rely on accurate reference standards of the active pharmaceutical ingredient, alongside its related compounds. This category includes pharmacopeial and non-pharmacopeial impurities, specific stereoisomers, degradation products, metabolites, and stable isotope-labelled compounds. These materials are essential for precise analytical testing, method validation, and comprehensive impurity profiling. Using these controlled compounds, laboratories can maintain rigorous quality control standards and ensure the consistency of chromatographic analysis throughout the development and lifecycle of pharmaceutical products.